September 26, 2017 12:31 PM ET

Biotechnology

Company Overview of Intrexon Corporation

Executive Profile

James S. Turley

Independent Director, Intrexon Corporation
AgeTotal Calculated CompensationThis person is connected to 6 Board Members in 6 organization across 9 different industries.

See Board Relationships
62$365,173

Background

Mr. James S. Turley, also known as Jim, serves as the Chairman of the National Corporate Theatre Fund. Mr. Turley served as the Chairman of Catalyst Inc. Mr. Turley has been an Independent Director of Northrop Grumman Corporation since February 19, 2015. He serves as a Director of Catalyst Inc. He has been a Director of Citigroup Inc. since July 2013 and has been an Independent Director of Emerson Electric Co. since July 10, 2013. He has been an Independent Director ...

Corporate Headquarters

20374 Seneca Meadows Parkway
Germantown, Maryland 20876

United States

Phone: 301-556-9900
Fax: --

Board Members Memberships

Director
Director
2013-Present
Independent Director
2013-Present
Director
2014-Present
Independent Director
2015-Present
Independent Director

Education

Bachelor's Degree
Rice University
Master's Degree
Rice University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

Exercisable Options$66,754
Exercisable Options Value$193,820
Unexercisable Options$20,702
Unexercisable Options Value$110,756
Total Value of Options$304,575
Total Number of Options$87,456

Total Compensation

Total Calculated Compensation$365,173
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
André Choulika Ph.D.Co-Founder, Chairman and Chief Executive Officer
Cellectis S.A.
$328.4K
Lewis T. Williams M.D., Ph.D.Founder, President, CEO & Chairman
Five Prime Therapeutics, Inc.
$885.8K
Richard A. Fair CEO, President & Director
Bellicum Pharmaceuticals, Inc.
--
James Julian Noble M.A., F.C.A.Chief Executive Officer and Director
Adaptimmune Therapeutics plc
$388.4K
Hans E. Bishop Co-Founder, Chief Executive Officer, President and Director
Juno Therapeutics, Inc.
$483.9K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Intrexon Corporation, please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.